• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Use of antihypertensives and the risk of Parkinson disease.

作者信息

Ascherio Alberto, Tanner Caroline M

出版信息

Neurology. 2009 Feb 10;72(6):578-9. doi: 10.1212/01.wnl.0000344171.22760.24.

DOI:10.1212/01.wnl.0000344171.22760.24
PMID:19204275
Abstract
摘要

相似文献

1
Use of antihypertensives and the risk of Parkinson disease.抗高血压药物的使用与帕金森病风险
Neurology. 2009 Feb 10;72(6):578-9. doi: 10.1212/01.wnl.0000344171.22760.24.
2
Use of antihypertensives and the risk of Parkinson disease.抗高血压药物的使用与帕金森病风险
Neurology. 2008 Apr 15;70(16 Pt 2):1438-44. doi: 10.1212/01.wnl.0000303818.38960.44. Epub 2008 Feb 6.
3
Temporary symptom worsening caused by manidipine hydrochloride in two patients with Parkinson's disease.
Mov Disord. 1994 Jan;9(1):106-7. doi: 10.1002/mds.870090119.
4
Are some antihypertensives more prone to induce hypotensive side effects than others?某些抗高血压药物是否比其他药物更容易引发低血压副作用？
Age Ageing. 2004 Nov;33(6):626-8. doi: 10.1093/ageing/afh196.
5
Are atypical antipsychotics associated with a reduced risk of developing parkinsonism?
Nat Clin Pract Neurol. 2006 Mar;2(3):132-3. doi: 10.1038/ncpneuro0129.
6
Parkinson's disease on treatment with Viskaldix.帕金森病使用维司力农治疗的情况。
J R Coll Gen Pract. 1984 Mar;34(260):184.
7
[Drug-induced Parkinson syndrome: 10 years of drug vigilance].[药物性帕金森综合征：十年药物警戒]
Therapie. 1994 Sep-Oct;49(5):459-60.
8
Hypertension management in the elderly.
Heart Dis Stroke. 1994 Mar-Apr;3(2):77-83.
9
Antihypertensive treatment and risk of cardiovascular complications: is the cure worse than the disease?
J Hypertens. 2009 Feb;27(2):221-3. doi: 10.1097/HJH.0b013e32831e9962.
10
[Orthostatic hypotension in patients with antihypertensive combination therapy].[联合降压治疗患者的体位性低血压]
MMW Fortschr Med. 2009 Jun 25;151(26-29):29-30.

引用本文的文献

1
The relation between Parkinson's disease and non-steroidal anti-inflammatories; a systematic review and meta-analysis.帕金森病与非甾体抗炎药之间的关系；一项系统评价与荟萃分析。
Front Pharmacol. 2024 Jul 31;15:1434512. doi: 10.3389/fphar.2024.1434512. eCollection 2024.
2
The role of the brain renin-angiotensin system in Parkinson´s disease.脑肾素-血管紧张素系统在帕金森病中的作用。
Transl Neurodegener. 2024 Apr 15;13(1):22. doi: 10.1186/s40035-024-00410-3.
3
Machine Learning Identifies Six Genetic Variants and Alterations in the Heart Atrial Appendage as Key Contributors to PD Risk Predictivity.
机器学习识别出心脏心耳中的六种基因变异和改变是帕金森病风险预测的关键因素。
Front Genet. 2022 Jan 3;12:785436. doi: 10.3389/fgene.2021.785436. eCollection 2021.
4
Modest CaV1.342-selective inhibition by compound 8 is β-subunit dependent.化合物8对CaV1.3 42亚基的适度抑制作用依赖于β亚基。
Nat Commun. 2014 Jul 24;5:4481. doi: 10.1038/ncomms5481.
5
Brain angiotensin and dopaminergic degeneration: relevance to Parkinson's disease.脑内血管紧张素与多巴胺能神经元变性：与帕金森病的相关性。
Am J Neurodegener Dis. 2012;1(3):226-44. Epub 2012 Nov 18.
6
Importance of the brain Angiotensin system in Parkinson's disease.脑内血管紧张素系统在帕金森病中的重要性。
Parkinsons Dis. 2012;2012:860923. doi: 10.1155/2012/860923. Epub 2012 Nov 7.
7
Anti-hypertensive drugs as disease-modifying agents for Parkinson's disease: evidence from observational studies and clinical trials.抗高血压药物作为帕金森病的疾病修饰药物：来自观察性研究和临床试验的证据。
Cochrane Database Syst Rev. 2011 Nov 9(11):CD008535. doi: 10.1002/14651858.CD008535.pub2.
8
Calcium channel blocker use and risk of Parkinson's disease.钙通道阻滞剂的使用与帕金森病风险。
Mov Disord. 2010 Sep 15;25(12):1818-22. doi: 10.1002/mds.23191.
9
L-type calcium channel blockers and Parkinson disease in Denmark.L 型钙通道阻滞剂与丹麦的帕金森病。
Ann Neurol. 2010 May;67(5):600-6. doi: 10.1002/ana.21937.
10
Anti-inflammatory drugs and risk of Parkinson disease: a meta-analysis.抗炎药物与帕金森病风险：一项荟萃分析。
Neurology. 2010 Mar 23;74(12):995-1002. doi: 10.1212/WNL.0b013e3181d5a4a3.